1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cerebral Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic Cerebral Stroke. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Ischemic Cerebral Stroke Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 48

List of Tables
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region, 2016* 6
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Ischemic Cerebral Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 13
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Ischemic Cerebral Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Ischemic Cerebral Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 16
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Ischemic Cerebral Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Ischemic Cerebral Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Ischemic Cerebral Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Ischemic Cerebral Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The North America and Europe stroke diagnostics market is expected to reach USD 1.4 million by 2024, according to a new report by Grand View Research Inc. The stroke diagnostics market is anticipated to ...

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global In Vitro Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.